Mankind Pharma announced its revenue growth of 19% YoY in Q4 FY23 and 12% YoY in FY23
New Delhi, India, May 30, 2023 (GNI): Mankind Pharma (BSE: 543904 | NSE: MANKIND) India’s fourth1 largest pharmaceutical Company today announced its financial results for the fourth quarter and full year ended March 31, 2023. The information…









